| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |